Brief: France Authorizes Reimbursed Compassionate Use of Agenus’ BOT/BAL for MSS Metastatic Colorectal Cancer
09/09/2025 12:47
Sept 9 (Reuters) - Agenus Inc AGEN.O: AGENUS: FRANCE GRANTS REIMBURSED COMPASSIONATE ACCESS FOR AGENUS' BOT/BAL IN REFRACTORY MSS METASTATIC COLORECTAL CANCER Source text: ID:nBw8GztGwa Further company coverage: AGEN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Agenus
See all newsBrief: Agenus Reports 72% Of Patients With Locally Advanced Dmmr Colon Cancer Had No Cancer Remaining At Surgery Following Six Weeks Of Bot+Bal In Phase 2 Neoasis Study At Esmo 2026
Brief: Armenia Grants First Marketing Authorizations For Agenus’ Bot+Bal In Previously Treated Mss Metastatic Colorectal Cancer
Brief: Agenus - Unit Enters Second Loan Modification Agreement With Ocean 1181 On Aug 12, 2026 - SEC Filing
Agenus Inc reports results for the quarter ended June 30 - Earnings Summary
Agenus Q2 revenue rises on access and royalty income